BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27278202)

  • 1. National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures.
    Minami CA; Wayne JD; Yang AD; Martini MC; Gerami P; Chandra S; Kuzel TM; Winchester DP; Palis BE; Bilimoria KY
    Ann Surg Oncol; 2016 Oct; 23(11):3548-3557. PubMed ID: 27278202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality.
    Kinnier CV; Paruch JL; Dahlke AR; Wayne JD; Benson AB; Winchester DP; Bilimoria KY
    Ann Surg; 2016 Feb; 263(2):392-8. PubMed ID: 26488806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Risk Factors in Lymphatic Surgeries for Melanoma: A National Surgical Quality Improvement Program Review.
    Ascha M; Ascha MS; Gastman B
    Ann Plast Surg; 2017 Nov; 79(5):509-515. PubMed ID: 28650410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
    Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
    Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
    Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
    J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
    Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
    Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
    Fritsch VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
    Scott JD; McKinley BP; Bishop A; Trocha SD
    Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node dissection in patients with malignant melanoma is associated with high risk of morbidity.
    Ul-Mulk J; Hölmich LR
    Dan Med J; 2012 Jun; 59(6):A4441. PubMed ID: 22677239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections.
    Shulman LN; Browner AE; Palis BE; Mallin K; Kakade S; Carp N; McCabe R; Winchester D; Wong SL; McKellar DP
    Ann Surg Oncol; 2019 Jun; 26(6):1613-1621. PubMed ID: 30927195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
    Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
    Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
    Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
    Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
    Wasif N; Gray RJ; Bagaria SP; Pockaj BA
    Melanoma Res; 2013 Aug; 23(4):276-82. PubMed ID: 23695440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
    Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
    Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
    de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
    Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland.
    Picon AI; Coit DG; Shaha AR; Brady MS; Boyle JO; Singh BB; Wong RJ; Busam KJ; Shah JP; Kraus DH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):9001-9009. PubMed ID: 16715435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
    Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
    Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.